Log In
Print this Print this

GLV-1h68 (GL-ONC1)

  Manage Alerts
Collapse Summary General Information
Company Genelux Corp.
DescriptionGenetically stable modified vaccinia virus that incorporates green fluorescent protein (GFP) to enable companion imaging
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityPreventive vaccine: Viral vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today